Show simple item record

dc.contributor.authorGreenshields, Anna L.
dc.date.accessioned2017-06-05T17:24:30Z
dc.date.available2017-06-05T17:24:30Z
dc.date.issued2017-06-05T17:24:30Z
dc.identifier.urihttp://hdl.handle.net/10222/72950
dc.description.abstractIn women, breast cancer is the most prevalent cancer diagnosis while ovarian cancer represents the most lethal gynecological neoplasm. The high incidence and mortality of these cancer types, in addition to the emergence of multi-drug resistant clones, highlights the need to develop novel therapeutic agents. Artesunate (ART) is a semi-synthetic derivative of artemisinin, a natural compound derived from the Chinese herb Artemisia annua L. ART is a potent anti-malarial agent that also possesses anticancer activity. Since the use of ART as an anti-malarial agent is associated with few adverse effects, ART may represent a less toxic alternative to conventional chemotherapy. This study investigates the cytotoxic effects of ART on breast and ovarian cancer cell lines and the mechanism(s) underlying its activity. ART exhibited a potent growth-inhibitory effect on a panel of breast and ovarian cancer cell lines. Anti-cancer activity was also observed in 3D cultures of both cancer cell types. Oregon Green488 and propidium iodide (PI) staining of cancer cells revealed that ART strongly inhibited cancer cell proliferation and, depending on the cell type, arrested cells in the G1 or G2/M phases of the cell cycle. Arrest in the G2/M phase was dependent on reactive oxygen species (ROS) production. The anti-proliferative effect of ART was associated with altered expression of several cell cycle regulatory proteins in both breast and ovarian cancer cell lines, including cyclin D3, E2F-1, and CDC25C. Annexin-V-FLUOS/PI staining of ARTtreated cancer cells revealed cytotoxicity against breast and ovarian cancer cell. ARTinduced cell death was iron- and ROS-dependent. Pre-treatment of cancer cells with a pan-caspase inhibitor decreased but did not eliminate ART-induced cancer cell death, suggesting that caspase-dependent apoptosis is involved in ART-mediated cancer cell killing. ART induced ROS-dependent DNA damage as indicated by the presence of γH2AX, which implicated the DNA damage pathway in ART-induced cancer cell death. These data show that ART has a potent anti-proliferative and cytotoxic effect on both breast and ovarian cancer cells. The cytotoxic activity of ART and its excellent safety record in malaria patients make ART a worthy candidate for further investigation as a possible treatment for breast and ovarian cancer.en_US
dc.subjectArtesunateen_US
dc.subjectOvaries--Cancer
dc.subjectBreast--Cancer
dc.subjectArtemisinin
dc.titleSTUDIES ON THE ANTI-CANCER PROPERTIES OF ARTESUNATE: ANTI-PROLIFERATIVE AND CYTOTOXIC EFFECTS ON BREAST AND OVARIAN CANCER CELLSen_US
dc.date.defence2014-01-20
dc.contributor.departmentDepartment of Pathologyen_US
dc.contributor.degreeDoctor of Philosophyen_US
dc.contributor.external-examinerDr. Anne-Marie Mes-Massonen_US
dc.contributor.graduate-coordinatorDr. Wenda Greeren_US
dc.contributor.thesis-readerDr. Robert Liwskien_US
dc.contributor.thesis-readerDr. Penny Barnesen_US
dc.contributor.thesis-readerDr. Karen Bedarden_US
dc.contributor.thesis-supervisorDr. David Hoskinen_US
dc.contributor.ethics-approvalNot Applicableen_US
dc.contributor.manuscriptsNot Applicableen_US
dc.contributor.copyright-releaseNot Applicableen_US
 Find Full text

Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record